These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 23532566)
1. Yeast-incorporated gallium attenuates glucocorticoid-induced bone loss in rats by inhibition of bone resorption. Ren Z; Yang L; Xue F; Meng Q; Wang K; Wu X; Ji C; Jiang T; Liu D; Zhou L; Zhang J; Fu Q Biol Trace Elem Res; 2013 Jun; 152(3):396-402. PubMed ID: 23532566 [TBL] [Abstract][Full Text] [Related]
2. Liraglutide increases bone formation and inhibits bone resorption in rats with glucocorticoid-induced osteoporosis. Yang L; Yang J; Pan T; Zhong X J Endocrinol Invest; 2019 Sep; 42(9):1125-1131. PubMed ID: 30955181 [TBL] [Abstract][Full Text] [Related]
3. Effects of the combined Herba Epimedii and Fructus Ligustri Lucidi on bone turnover and TGF-β1/Smads pathway in GIOP rats. Yang Y; Nian H; Tang X; Wang X; Liu R J Ethnopharmacol; 2017 Apr; 201():91-99. PubMed ID: 28254481 [TBL] [Abstract][Full Text] [Related]
4. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats. Xu D; Yang W; Zhou C; Liu Y; Xu B Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944 [TBL] [Abstract][Full Text] [Related]
5. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone. Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508 [TBL] [Abstract][Full Text] [Related]
6. Preventative effects of metformin on glucocorticoid-induced osteoporosis in rats. Zhao J; Li Y; Zhang H; Shi D; Li Q; Meng Y; Zuo L J Bone Miner Metab; 2019 Sep; 37(5):805-814. PubMed ID: 30706148 [TBL] [Abstract][Full Text] [Related]
7. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis. Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393 [TBL] [Abstract][Full Text] [Related]
8. [The effects of glucocorticoid on expression of cannabinoid-1 receptors in osteoclasts from tibial proximal metaphysis of rats]. Liu SP; Chen J; Dai RC; Yang SM; Li JW; Wu XP; Liao EY Zhonghua Nei Ke Za Zhi; 2009 Feb; 48(2):144-8. PubMed ID: 19549472 [TBL] [Abstract][Full Text] [Related]
9. Ginsenosides Rg3 attenuates glucocorticoid-induced osteoporosis through regulating BMP-2/BMPR1A/Runx2 signaling pathway. Zhang X; Chen K; Wei B; Liu X; Lei Z; Bai X Chem Biol Interact; 2016 Aug; 256():188-97. PubMed ID: 27387537 [TBL] [Abstract][Full Text] [Related]
10. Influence of glucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry. Ogoshi T; Hagino H; Fukata S; Tanishima S; Okano T; Teshima R Mod Rheumatol; 2008; 18(6):552-61. PubMed ID: 18648735 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the therapeutic effects of yeast-incorporated gallium with those of inorganic gallium on ovariectomized osteopenic rats. Ma Z; Fu Q Biol Trace Elem Res; 2010 Jun; 134(3):280-7. PubMed ID: 19652924 [TBL] [Abstract][Full Text] [Related]
12. Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. Dalle Carbonare L; Bertoldo F; Valenti MT; Zordan S; Sella S; Fassina A; Turco G; Realdi G; Lo Cascio V; Giannini S J Endocrinol Invest; 2007 Oct; 30(9):739-46. PubMed ID: 17993765 [TBL] [Abstract][Full Text] [Related]
13. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG). Sasaki N; Kusano E; Takahashi H; Ando Y; Yano K; Tsuda E; Asano Y J Bone Miner Metab; 2005; 23(1):41-7. PubMed ID: 15616893 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of necrostatin-1 on glucocorticoid-induced osteoporosis in rats. Feng M; Zhang R; Gong F; Yang P; Fan L; Ni J; Bi W; Zhang Y; Wang C; Wang K J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():455-62. PubMed ID: 25220755 [TBL] [Abstract][Full Text] [Related]
15. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment. Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179 [TBL] [Abstract][Full Text] [Related]
16. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment. Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210 [TBL] [Abstract][Full Text] [Related]
18. Yeast-incorporated gallium promotes fracture healing by increasing callus bony area and improving trabecular microstructure on ovariectomized osteopenic rats. Pei Y; Fu Q Biol Trace Elem Res; 2011 Jun; 141(1-3):207-15. PubMed ID: 20446054 [TBL] [Abstract][Full Text] [Related]
19. Effects of glucocorticoid-induced osteoporosis on bone tissue of rats with experimental periodontitis. Sousa LH; Moura EV; Queiroz AL; Val D; Chaves H; Lisboa M; Furlaneto F; Brito GA; Goes P Arch Oral Biol; 2017 May; 77():55-61. PubMed ID: 28178585 [TBL] [Abstract][Full Text] [Related]
20. Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats. Wang L; Zhang HY; Gao B; Shi J; Huang Q; Han YH; Hu YQ; Lu WG; Zhao ZJ; Liu BH; Jie Q; Yang L; Luo ZJ Stem Cells Dev; 2017 Mar; 26(6):419-430. PubMed ID: 27917698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]